The most novel finding in this study was that high levels of baseline adiponectin were associated with less reduction in β-cell function over time in this observational Mexican-American cohort at risk for type 2 diabetes, independent of weight gain, insulin resistance and fourteen other adipokines. The gene discussed is ADIPOQ; the disease is Insulin resistance.